BioSpace News Archive

Biosimilars have been slow to gain traction in the U.S. market. Some of this is intentional on the part of the drug industry, which has found a number of different approaches to stalling biosimilar competition.

Panel is the only direct-from-blood diagnostic designed to detect genetic markers associated with antibiotic-resistant bloodstream infections

Ms. Ball has held senior global leadership roles in the life sciences industry for more than 18 years

The NOAA RESTORE Science Program has awarded approximately $15.6 million in grants to four teams of researchers and resource managers from across 20 institutions including universities, federal and state agencies and non-governmental organizations to support work on living coastal and marine resources and their habitats in the Gulf of Mexico.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

Araris Biotech AG announced the appointment of Dr. Rakesh Dixit, Dr. John Lambert and Dr. L. Nathan Tumey as members of its Scientific Advisory Board.

Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting

Top-line results expected in second half of 2020

RFPi Inc. has received a grant from the National Institutes of Health to develop a novel, imaging-based medical device that health-care providers could use to test asymptomatic patients at risk for peripheral arterial disease.

PDS0101- KEYTRUDA® (pembrolizumab) Combination to be Evaluated in First Line Treatment of Metastatic Head and Neck Cancer